| Literature DB >> 34848928 |
Vahid Darvishi1, Mahdi Navidbakhsh1, Saeid Amanpour2.
Abstract
In this study, a more precise and cost-effective method is used for studying the drug delivery and distribution of magnetic nanoparticles in fluid hyperthermia cancer treatment, and numerical methods are employed to determine the effect of blood circulation on heat transfer and estimate the success of cancer treatment. A combination of numerical, analytical, and experimental researches is being conducted, which illustrates the essential role of numerical methods in medical and biomedical science. Magnetic NanoParticles' distribution and effects of infusion rate on the treatment are also discussed by considering the real distribution of MNPs. To increase accuracy and reduce costs in the in-vitro section, direct cutting and image processing methods are used instead of MRI. Based on the results of this section, with a tenfold increase in the infusion rate (4 μl/min to 40 μl/min), the penetration depth increases by 1 mm, which represents a nearly 17 percent increase. Concentrations of MNPs also decrease significantly at higher infusion rates. The simulations of heat transfer reveal that maximum temperatures occur at the lowest infusion rate (1.25 μl/min), and blood flow also has a significant effect on heat transfer. With an increase in the infusion rate, necrosis tissue recedes from the tumor center and approaches the border between the tumor and healthy tissue. Results also show that, in lower MNPs' concentrations, higher infusion rates result in better treatment even though minimum infusion rates are suggested to be the best rates to facilitate distribution and treatment.Entities:
Year: 2021 PMID: 34848928 PMCID: PMC8624640 DOI: 10.1007/s00231-021-03161-3
Source DB: PubMed Journal: Heat Mass Transf ISSN: 0947-7411 Impact factor: 2.325
Fig. 1Length and width used to measure the distribution
Fig. 2(A) The original image. (B) Image after cutting into a 9 mm * 6 mm image. (C) Image after image processing
Fig. 3(A) The geometry of the simulated tumor and the surrounding healthy tissue [41]. (B) The geometry after adding nanoparticles
Mechanical properties of the healthy and tumor tissue used in simulation [42–44]
| Property | Symbol | Tissue type | |
|---|---|---|---|
| Specific Heat ( | 3760 | 3760 | |
| Density ( | 1045 | 1045 | |
| Thermal Conductivity ( | 0.51 | 0.51 | |
| Pre-factor ( | 1.80E36 | 1.03E38 | |
| Activation Energy ( | 2.38E5 | 2.49E5 | |
| Point Heat Source ( | 0.016 | 0 | |
| Perfusion Rate ( | 0.0095 | 0.003 | |
| Metabolic Heat Rate ( | 31,872.5 | 6374.5 | |
Mechanical properties of the blood used in simulation[42, 44]
| Property | Symbol | blood |
|---|---|---|
| Specific Heat ( | 3770 | |
| Density ( | 1060 | |
| Temperature ( |
Comparison of maximum temperature for different mesh types
| Mesh type | Element size(mm) | Total number of elements | Maximum temperature (°C) | |
|---|---|---|---|---|
| Max | Min | |||
| Normal | 1.27 | 0.0057 | 5666 | 51.28088 |
| Fine | 1.01 | 0.0057 | 5884 | 51.2809 |
| Finer | 0.703 | 0.00238 | 7026 | 51.28094 |
| Extra Fine | 0.38 | 0.00142 | 17,347 | 51.28519 |
| Extremely Fine | 0.19 | 3.8E-4 | 33,276 | 51.28505 |
Comparison of maximum temperature for different time steps
| Time step(s) | 0.1 | 0.5 | 1 | 2 | 10 |
|---|---|---|---|---|---|
| Maximum temperature (°C) | 51.28088 | 51.28088 | 51.28088 | 51.28088 | 51.28088 |
Fig. 4Radial distribution of temperature in the tissue after 600 s, a comparison between present work and Lin and Liu’s [48]
Fig. 5Distribution length and width in MNPs injection with different concentrations and infusion rates
Fig. 6Concentration of MNPs in the tissue. (A) Injection of 100 of magnetic fluid with an infusion rate of 1.25 . (B) Injection of 100 of magnetic fluid with an infusion rate of 104.06
The maximum produced temperature for different injection volumes and infusion rates
| Test number | Injection volume & infusion rate | Maximum produced temperature for sample… (°C) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No blood in both healthy and tumor tissue | Having blood just in healthy tissue | Having blood in both healthy and tumor tissue | ||||||||
| 1 | 50 | 48.7923 | - | - | 48.3825 | - | - | 46.005 | - | - |
| 2 | 50 | 47.8011 | - | - | 47.3684 | - | - | 45.093 | - | - |
| 3 | 100 | 57.2387 | 56.4372 | - | 56.4382 | 55.6637 | 51.985 | 51.562 | - | |
| 4 | 100 | 55.8848 | 56.0444 | 57.0162 | 55.0797 | 55.2389 | 56.2428 | 51.033 | 51.280 | 52.006 |
| 5 | 100 | 54.0376 | 55.9015 | 55.9163 | 53.2398 | 55.1175 | 55.1257 | 49.189 | 50.931 | 50.953 |
| 6 | 100 | 54.4726 | 54.1680 | - | 53.7006 | 53.3390 | - | 49.636 | 49.535 | - |
| 7 | 200 | 70.6874 | - | - | 69.1438 | - | - | 64.360 | - | - |
| 8 | 100 | 52.5343 | - | - | 51.7507 | - | - | 48.216 | - | - |
Fig. 7The fraction of necrotic tissue after 1200 s. (A) Infusion rate = 1.25 . (B) Infusion rate = 10 . (C) Infusion rate = 40 . (D) Infusion rate = 80 . (E) Infusion rate = 104.06 . (F) Uniform distribution (control model)